Insights › Market reaction

Why Viridian Therapeutics (VRDN) Stock Rose 3.73% in 10 Minutes After Q3 Earnings on Nov 4, 2026

EPS of -$0.81 came in above the -$1.00 estimate.

Published in ET: Feed time in ET: Earnings VRDN +3.73% in 10 min after the headline
  • VRDN rose 3.73% in the 10 minutes after the 07:04:48 ET headline, from $26.55 to $27.54.
  • 50,778 shares changed hands in those 10 minutes.
  • The headline crossed in pre-market trading, 2 hours 26 minutes before the 9:30 ET open.
VRDN Why Viridian Therapeutics (VRDN) Stock Rose 3.73% in 10 Minutes After Q3 Earnings on Nov 4,
MoveSurge publish 07:04:48 ET
MoveSurge publish
07:04:48 ET
28.66 27.88 27.06 26.28 27.54 07:02 07:04 07:14
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
VRDN 26.55 26.55 27.50 27.54 +3.58% +3.73%

Viridian Therapeutics (VRDN) shares rose 3.73% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 07:04:48 ET on Wednesday, November 4, 2026. EPS of -$0.81 came in above the -$1.00 estimate.

VRDN in the first 10 minutes

The line that crossed at 07:04:48 ET: “VRDN Q3: EPS -0.81 vs -1 est”

From a reference price of $26.55 just before the headline, the stock was up 3.58% after one minute and up 3.73%, at $27.54, after 10 minutes. The first-minute move held. 50,778 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 2 hours 26 minutes before the 9:30 ET open.

Viridian Therapeutics Q3 results against estimates

MeasureReportedEstimateResult
EPS-$0.81-$1.00Beat

How VRDN traded after earlier earnings releases

ReportEPS vs estimateRevenue vs estimateFirst move
Aug 6, 2026-1.05 vs -1.02—not measured

Viridian Therapeutics at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$2.85 billion (as of Nov 4, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

How did Viridian Therapeutics stock react to its Q3 earnings on November 4, 2026?

The stock rose 3.73% in the 10 minutes after its Q3 results crossed at 07:04:48 ET. EPS of -$0.81 came in above the -$1.00 estimate.

How far did VRDN move after the headline?

From $26.55 just before the headline to $27.54 10 minutes later, a +3.73% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Go live — 7 days for $29 Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.